Nemaura Medical, Inc. (NMRD)
Nemaura Medical, Inc. (NMRD), is a medical technology company developing non-invasive and minimally invasive wearable diagnostic devices, coupled with artificial intelligence capabilities for digital healthcare. Nemaura Medical evolved from a Micro-system based drug delivery platform in 2011. Since then we have developed the platform to allow the monitoring of multiple chemicals in the blood, without using needles. Replacing traditional invasive methods of diagnosis and healthcare observation procedures, our BEAT technology will allow for remote continuous monitoring of chronic diseases and health conditions. With over 420 million people worldwide with diabetes and the number of pre-diabetes cases at almost three times this number, diabetes is an urgent global health crisis.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Occupational Health
- Market Focus:
- Globally (various continents)
About us
One of the great advantages of our product apart from the fact that you no longer need to draw blood samples or insert a needle or sensor inside the skin, is that a person can wear the device on whatever day they choose and for however long they choose. This is a unique feature of our device and a world first, opening up vast potential for changing the way we manage chronic disease conditions.
The company’s first product, which is CE approved and undergoing commercial launch, is the sugarBEAT® non- invasive continuous glucose monitoring device and BEAT®diabetes digital healthcare platform. sugarBEAT® is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which help people with Type 1 or Type 2 diabetes and prediabetes respectively to better manage, reverse and prevent the onset of diabetes. BEAT®diabetes is a health subscription service providing 1-on-1 lifestyle coaching and behavior change recommendations driven by personalized data provided by sugarBEAT®. Insulin users can also adjunctively use sugarBEAT® for insulin dosage purposes when calibrated by a finger stick reading.
sugarBEAT® is intended to be worn during waking hours and consists of a daily disposable adhesive skin-patch connected to a rechargeable transmitter, with an app displaying glucose readings at five-minute intervals.